Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2023-08-08 Director's Dealing
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 31 - 2023
Director's Dealing Classification · 1% confidence The document text consists primarily of tables detailing stock transactions, including 'Jour de la transaction' (Date of transaction), 'Volume total journalier' (Total daily volume), 'Prix pondéré moyen journalier' (Weighted average price), and specific transaction details involving 'Quantité achetée' (Quantity bought) and 'Prix Unitaire' (Unit Price). The presence of transaction dates (e.g., 31/07/2023, 01/08/2023) and the nature of the data strongly indicate a report detailing personal share transactions by directors or executives, or related insider activity. This aligns perfectly with the definition of 'Director's Dealing' (Code: DIRS). It is not a general financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-08-08 English
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2023
Director's Dealing Classification · 1% confidence The document text consists almost entirely of tables detailing transactions involving the issuer 'IPSEN'. Key columns include 'Name of issuer', 'Day of transaction', 'Identification code of financial instrument', 'Aggregated daily volume (in number of shares)', and 'Price per transaction'. The presence of transaction dates (e.g., 31/07/2023, 01/08/2023) and specific transaction reference numbers, along with columns indicating 'Purpose of buy back' (though mostly empty, suggesting reporting of trades), strongly indicates a filing related to insider trading or director/executive share dealings. This aligns perfectly with the definition for Director's Dealing (DIRS). It is not a comprehensive financial report (10-K, IR), an earnings release (ER), or a general regulatory announcement (RNS), but a specific report on share transactions by insiders/related parties.
2023-08-08 English
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it provides 'Monthly information relative to the total number of voting rights and shares composing the share capital' and references French regulatory articles (AMF). This type of regular disclosure detailing the total share count and voting rights is a standard regulatory filing, often required monthly or quarterly. It does not fit the specific definitions for AGM materials, Annual Reports (10-K), Earnings Releases (ER), or Director's Dealing (DIRS). Since it is a specific, recurring regulatory disclosure that doesn't fit the other specialized categories (like NAV, DIV, or DVA which deals with *results* of votes), the most appropriate classification is the general regulatory filing category, RNS, or potentially a specialized category if one existed for voting rights disclosure. Given the options, RNS (Regulatory Filings) serves as the best fit for a mandatory, recurring regulatory update that isn't a primary financial report or a specific event announcement.
2023-08-04 English
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a monthly update (as of July 31, 2023) detailing the total number of shares and voting rights (gross and net). This content directly relates to changes in the capital structure and voting rights, which aligns best with the 'Share Issue/Capital Change' category (SHA) or potentially a general regulatory filing (RNS). Given the specific nature of reporting total voting rights and share capital monthly, SHA is the most precise fit, as it covers capital structure changes, even if this is a routine disclosure rather than a major issuance announcement. It is not an AGM, 10-K, ER, or IR. It is a specific capital structure disclosure.
2023-08-04 French
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 30 - 2023
Director's Dealing Classification · 1% confidence The document text consists of detailed tables showing transactions involving the issuer 'IPSEN' and specific counterparties ('Exane SA') over several days (July 24-25, 2023). The tables include columns like 'Volume total journalier (en nombre d'actions)', 'Prix pondéré moyen journalier d'acquisition des actions', 'Quantité achetée', and 'Prix Unitaire'. This structure is characteristic of mandatory disclosures regarding insider trading or significant share transactions by directors/executives or major shareholders. Reviewing the definitions, the category 'Director's Dealing (Code: DIRS)' covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although the document might be a regulatory filing related to share transactions, the specific content detailing individual transactions by an entity (which could be an insider or a major shareholder acting on behalf of one) strongly aligns with the scope of DIRS or potentially MRQ (Major Shareholding Notification). However, the granular, day-by-day transaction detail, often required for insider transactions, points more directly to DIRS, which covers director/executive dealings. Given the context of detailed transaction reporting, DIRS is the most appropriate fit over the broader MRQ or the general fallback RNS.
2023-08-01 French
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2023
Transaction in Own Shares Classification · 1% confidence The document text consists almost entirely of tables detailing transactions involving the issuer 'IPSEN'. Key columns include 'Name of issuer', 'Day of transaction', 'Identification code of financial instrument', 'Aggregated daily volume (in number of shares)', and 'Daily weighted average price of the purchased shares'. The presence of transaction dates (e.g., 24/07/2023, 25/07/2023) and specific transaction reference numbers, along with columns explicitly detailing 'Purpose of buy back' (though empty in the visible snippet), strongly indicates a report detailing the company's own share transactions. This aligns directly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance reports.
2023-08-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.